Sarah Cannon to Present Latest Cancer Research Insights at 2021 ASCO® Annual Meeting

This year, SCRI’s drug development, molecular profiling, and clinical care expertise is featured through 119 abstracts and presentations, including data from 70 phase 1 studies.